3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Thrombocytopenia
1
Hematologic Neoplasms
1
Interventions
eltrombopag
6
romiplostim
4
avatrombopag
4
Cytarabine
4
Daunorubicin
3
Cyclophosphamide
3
oprelvekin
2
hetrombopag
2
Tretinoin
2
Tranexamic Acid
2
Radiotherapy
2
Platelet Transfusion
2
Filgrastim
2
Etoposide
2
Carboplatin
2
sodium thiosulfate
1
raltitrexed
1
pegfilgrastim
1
ofatumumab
1
niraparib
1
leridistim
1
fludarabine
1
etoposide phosphate
1
angiotensin I (1-7)
1
Vorinostat
1
Vincristine
1
Thioguanine
1
Stem Cell Transplantation
1
Sirolimus
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Thrombocytopenia
×
Aminocaproic Acid
×
Clear all
NCT02074436
2022-07-19
PROBLEMA
Emory University
Phase 2
Terminated
29 enrolled
10 charts